Niva Bupa Health Insurance: Premium growth momentum continues in July 2026, while hospitalization trend is in line with expectation; Buy

Research evidence excerpt

Niva Bupa Health Insurance: Premium growth momentum continues in July 2026, while hospitalization trend is in line with expectation; Buy

the Financial Advisers Regulations. This document is intended for accredited,

expert or institutional investors as defined by the Securities and Futures Act (Chapter 289). Where the recipient of this document is not an

accredited, expert or institutional investor, NSL accepts legal responsibility for the contents of this document in respect of such recipient only to

the extent required by law. Recipients of this document in Singapore should contact NSL in respect of matters arising from, or in connection

with, this document. THIS DOCUMENT IS INTENDED FOR GENERAL CIRCULATION. IT DOES NOT TAKE INTO ACCOUNT THE SPECIFIC

INVESTMENT OBJECTIVES, FINANCIAL SITUATION OR PARTICULAR NEEDS OF ANY PARTICULAR PERSON. RECIPIENTS SHOULD

TAKE INTO ACCOUNT THEIR SPECIFIC INVESTMENT OBJECTIVES, FINANCIAL SITUATION OR PARTICULAR NEEDS BEFORE

MAKING A COMMITMENT TO PURCHASE ANY SECURITIES, INCLUDING SEEKING ADVICE FROM AN INDEPENDENT FINANCIAL

ADVISER REGARDING THE SUITABILITY OF THE INVESTMENT, UNDER A SEPARATE ENGAGEMENT, AS THE RECIPIENT DEEMS FIT.

Unless prohibited by the provisions of Regulation S of the 1933 Act, this material is distributed in the US, by NSI, a US-registered broker-dealer,

which accepts responsibility for its contents in accordance with the provisions of Rule 15a-6, under the US Securities Exchange Act of 1934.

The entity that prepared this document permits its separately operated affiliates within the Nomura Group to make copies of such documents

available to their clients.

This document has not been approved for distribution to persons other than ‘Authorised Persons’, ‘Exempt Persons’ or ‘Institutions’ (as defined